148 related articles for article (PubMed ID: 28419443)
41. A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm.
Revermann M; Mieth A; Popescu L; Paulke A; Wurglics M; Pellowska M; Fischer AS; Steri R; Maier TJ; Schermuly RT; Geisslinger G; Schubert-Zsilavecz M; Brandes RP; Steinhilber D
Br J Pharmacol; 2011 Aug; 163(8):1721-32. PubMed ID: 21410457
[TBL] [Abstract][Full Text] [Related]
42. Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1.
Han Y; Jiang Z; Chen Z; Gu Y; Liu Y; Zhang X; Cao X
J Autoimmun; 2015 Apr; 58():21-35. PubMed ID: 25592391
[TBL] [Abstract][Full Text] [Related]
43. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
44. CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs.
Wang C; Liu X; Li Z; Chai Y; Jiang Y; Wang Q; Ji Y; Zhu Z; Wan Y; Yuan Z; Chang Z; Zhang M
Sci Rep; 2015 Sep; 5():14124. PubMed ID: 26369936
[TBL] [Abstract][Full Text] [Related]
45. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
46. NKT cell-dependent regulation of secondary antigen-specific, conventional CD4+ T cell immune responses.
Shin Y; Hong C; Lee H; Shin JH; Hong S; Park SH
J Immunol; 2010 May; 184(10):5589-94. PubMed ID: 20375305
[TBL] [Abstract][Full Text] [Related]
47. Histamine receptor 2 modifies iNKT cell activity within the inflamed lung.
Ferstl R; Frei R; Barcik W; Schiavi E; Wanke K; Ziegler M; Rodriguez-Perez N; Groeger D; Konieczna P; Zeiter S; Nehrbass D; Lauener R; Akdis CA; O'Mahony L
Allergy; 2017 Dec; 72(12):1925-1935. PubMed ID: 28618071
[TBL] [Abstract][Full Text] [Related]
48. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of mutant KrasG12D-initiated murine pancreatic carcinoma growth by a dual c-Raf and soluble epoxide hydrolase inhibitor t-CUPM.
Liao J; Hwang SH; Li H; Yang Y; Yang J; Wecksler AT; Liu JY; Hammock BD; Yang GY
Cancer Lett; 2016 Feb; 371(2):187-93. PubMed ID: 26683769
[TBL] [Abstract][Full Text] [Related]
50. BTK signaling drives CD1d
Das S; Bar-Sagi D
Oncogene; 2019 Apr; 38(17):3316-3324. PubMed ID: 30635655
[TBL] [Abstract][Full Text] [Related]
51. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages.
Song L; Asgharzadeh S; Salo J; Engell K; Wu HW; Sposto R; Ara T; Silverman AM; DeClerck YA; Seeger RC; Metelitsa LS
J Clin Invest; 2009 Jun; 119(6):1524-36. PubMed ID: 19411762
[TBL] [Abstract][Full Text] [Related]
52. Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.
McAllister F; Bailey JM; Alsina J; Nirschl CJ; Sharma R; Fan H; Rattigan Y; Roeser JC; Lankapalli RH; Zhang H; Jaffee EM; Drake CG; Housseau F; Maitra A; Kolls JK; Sears CL; Pardoll DM; Leach SD
Cancer Cell; 2014 May; 25(5):621-37. PubMed ID: 24823639
[TBL] [Abstract][Full Text] [Related]
53. Ligand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade.
Saroj Devi N; Shanmugam R; Ghorai J; Ramanan M; Anbarasan P; Doble M
Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991413
[TBL] [Abstract][Full Text] [Related]
54. Natural killer T cells suppress zymosan A-mediated granuloma formation in the liver by modulating interferon-γ and interleukin-10.
Kobayashi T; Kawamura H; Kanda Y; Matsumoto H; Saito S; Takeda K; Kawamura T; Abo T
Immunology; 2012 May; 136(1):86-95. PubMed ID: 22268994
[TBL] [Abstract][Full Text] [Related]
55. CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice.
Minegishi Y; Hiroshima Y; Yazawa K; Sato S; Yabushita Y; Homma Y; Matsuyama R; Kato I; Goshima Y; Endo I
Anticancer Res; 2022 Feb; 42(2):791-799. PubMed ID: 35093877
[TBL] [Abstract][Full Text] [Related]
56. IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.
Liu D; Song L; Wei J; Courtney AN; Gao X; Marinova E; Guo L; Heczey A; Asgharzadeh S; Kim E; Dotti G; Metelitsa LS
J Clin Invest; 2012 Jun; 122(6):2221-33. PubMed ID: 22565311
[TBL] [Abstract][Full Text] [Related]
57. 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth.
Hennig R; Kehl T; Noor S; Ding XZ; Rao SM; Bergmann F; Fürstenberger G; Büchler MW; Friess H; Krieg P; Adrian TE
Neoplasia; 2007 Nov; 9(11):917-26. PubMed ID: 18030360
[TBL] [Abstract][Full Text] [Related]
58. Nanoparticle Delivery of RIG-I Agonist Enables Effective and Safe Adjuvant Therapy in Pancreatic Cancer.
Das M; Shen L; Liu Q; Goodwin TJ; Huang L
Mol Ther; 2019 Mar; 27(3):507-517. PubMed ID: 30545600
[TBL] [Abstract][Full Text] [Related]
59. Surveillance for familial pancreatic cancer.
de Vos tot Nederveen Cappel WH; Lagendijk MA; Lamers CB; Morreau H; Vasen HF
Scand J Gastroenterol Suppl; 2003; (239):94-9. PubMed ID: 14743890
[TBL] [Abstract][Full Text] [Related]
60. Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.
Bastea LI; Liou GY; Pandey V; Fleming AK; von Roemeling CA; Doeppler H; Li Z; Qiu Y; Edenfield B; Copland JA; Tun HW; Storz P
Cancer Res; 2019 Apr; 79(7):1535-1548. PubMed ID: 30696657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
